Charles Reinhart III — Chief Financial Officer at Pacira Pharmaceuticals

Mr. Charles A. Reinhart, III, also known as Charlie, has been Chief Financial Officer at Pacira Pharmaceuticals, Inc. since May 03, 2016. Mr. Reinhart is responsible for overseeing all financial and capital market activities at Pacira, including accounting, financial reporting, financial planning and analysis and investor relations. Prior to joining Pacira, he served as Chief Financial Officer of Covis Pharmaceuticals, Inc. He served as Chief Financial Officer and Executive Vice President at Archimedes Pharma Limited since September 2011. He joined Archimedes Pharma in September 2011. Mr. Reinhart served as Chief Financial Officer and Senior Vice President at PharmAthene, Inc. from August 14, 2009 to September 7, 2011 and had oversees its accounting and finance functions, human resources and information technology. Prior to PharmAthene, Mr. Reinhart served as Senior Vice President of Finance and Corporate Strategy and a member of the Operating Leadership Team of Millennium Pharmaceuticals, Inc., where he was responsible for all aspects of its finance and strategic sourcing functions. He has 30 years of diversified experience in executive management, strategic planning, debt and equity financing, investor relations, business development, accounting and financial reporting, tax, treasury, financial planning and analysis and risk management. Mr. Reinhart has successfully built and managed finance organizations within rapidly growing companies, responsible for accounting and financial reporting, financial planning and analysis, tax, treasury, risk management and procurement. He has worked closely with commercial teams to evaluate sales operations, monitor product pricing and implement contracting strategies. In addition, he has significant experience in investor relations, corporate development and capital raising. He has been integrally involved in equity and debt financing transactions, as well as the evaluation, acquisition and integration of multiple products and companies. Mr. Reinhart served as Vice President of Finance at Cephalon, Inc. where he was responsible for worldwide accounting, financial reporting, Sarbanes Oxley compliance, tax, treasury and budgeting/forecasting functions. He served as Chief Financial Officer, Vice President and Treasurer of Delsys Pharmaceutical Corporation. Prior to joining Delsys, Mr. Reinhart worked as the Director of Finance and Administration at GenVec, Inc. He served as Chief Financial Officer for Dynamic Digital Displays. He held various positions for Ernst & Whinney (now Ernst & Young), including Manager, in the audit department. He serves as a Director of VectorLogics, Inc. Mr. Reinhart is a Certified Public Accountant. He earned his Masters of Business Administration from The Wharton School at the University of Pennsylvania and earned his Bachelor of Science degree in Business and Economics from Lehigh University.